Charles Bennett to Humans
This is a "connection" page, showing publications Charles Bennett has written about Humans.
Connection Strength
4.220
-
Humira: the first $20 billion drug. Am J Manag Care. 2023 02; 29(2):78-80.
Score: 0.032
-
Using Twitter for the identification of COVID-19 vaccine-associated haematological adverse events. Lancet Haematol. 2022 01; 9(1):e12-e13.
Score: 0.030
-
Fluoroquinolone-Associated Disability and Other Fluoroquinolone-Associated Serious Adverse Events: Unexpected Toxicities Have Emerged in Recent Years. Cancer Treat Res. 2022; 184:1-39.
Score: 0.030
-
Biosimilar Epoetin in the United States: A View from the Southern Network on Adverse Reactions. Cancer Treat Res. 2022; 184:41-51.
Score: 0.030
-
Policing of Drug Safety Information Dissemination Under the False Claims Act. Cancer Treat Res. 2022; 184:53-59.
Score: 0.030
-
Translating Research into Health Policy: The Citizen Petition Experience with the Food and Drug Administration. Cancer Treat Res. 2022; 184:61-73.
Score: 0.030
-
Systemic Barriers and Potential Concerns from Reporting Serious Adverse Drug Reactions. Cancer Treat Res. 2022; 184:75-85.
Score: 0.030
-
Was There Something Rotten in Denmark: Nephrogenic System Fibrosis Cases Occurring in Copenhagen. Cancer Treat Res. 2022; 184:87-102.
Score: 0.030
-
Rituximab-Associated Progressive Multifocal Leukoencephalopathy: A Twenty-Year Update. Cancer Treat Res. 2022; 184:103-111.
Score: 0.030
-
Maximum Accuracy Machine Learning Statistical Analysis-A Novel Approach. Cancer Treat Res. 2022; 184:113-127.
Score: 0.030
-
Investigating Severe Adverse Reactions: Examples of the ANTICIPATE Methodology at Work. Cancer Treat Res. 2022; 184:129-140.
Score: 0.030
-
Consequences to Patients, Clinicians, and Manufacturers When Very Serious Adverse Drug Reactions Are Identified (1997-2019): A Qualitative Analysis from the Southern Network on Adverse Reactions (SONAR). Cancer Treat Res. 2022; 184:141-149.
Score: 0.030
-
Moderna, Pfizer-BioNTech, and Johnson & Johnson/Janssen Post-Covid Vaccine Hematological Adverse Events Including Cerebral Venous Sinus Thrombosis (CVST), Thrombotic Thrombocytopenia (VITT), Blood Clots, Increased Vaginal/Menstrual Bleeding and/or Miscarriage, Stillbirth Delivery, or Premature Birth. Cancer Treat Res. 2022; 184:151-160.
Score: 0.030
-
Progressive multifocal leukoencephalopathy in patients treated with rituximab: a 20-year review from the Southern Network on Adverse Reactions. Lancet Haematol. 2021 Aug; 8(8):e593-e604.
Score: 0.029
-
The First 2?Years of Biosimilar Epoetin for Cancer and Chemotherapy-Induced Anemia in the U.S.: A Review from the Southern Network on Adverse Reactions. Oncologist. 2021 08; 26(8):e1418-e1426.
Score: 0.028
-
Contemporary Clinical Trials Office: Doing More With Less. JCO Oncol Pract. 2021 01; 17(1):1-2.
Score: 0.028
-
Improving oncology biosimilar launches in the EU, the USA, and Japan: an updated Policy Review from the Southern Network on Adverse Reactions. Lancet Oncol. 2020 12; 21(12):e575-e588.
Score: 0.028
-
End of an era of administering erythropoiesis stimulating agents among Veterans Administration cancer patients with chemotherapy-induced anemia. PLoS One. 2020; 15(6):e0234541.
Score: 0.027
-
End of an era for erythropoiesis-stimulating agents in oncology. Int J Cancer. 2020 05 15; 146(10):2829-2835.
Score: 0.026
-
Caveat Medicus: Clinician experiences in publishing reports of serious oncology-associated adverse drug reactions. PLoS One. 2019; 14(7):e0219521.
Score: 0.025
-
Major hemorrhage in chronic lymphocytic leukemia patients in the US Veterans Health Administration system in the pre-ibrutinib era: Incidence and risk factors. Cancer Med. 2019 05; 8(5):2233-2240.
Score: 0.025
-
Regulatory and Clinical Experiences with Biosimilar Filgrastim in the U.S., the European Union, Japan, and Canada. Oncologist. 2019 04; 24(4):537-548.
Score: 0.025
-
Biosimilar Filgrastim Use in the United States vs the European Union and Japan-Why Does It Lag Behind and What Can Be Done? JAMA Oncol. 2019 03 01; 5(3):297-298.
Score: 0.025
-
EDITORIAL COMMENT. Urology. 2019 01; 123:119.
Score: 0.024
-
Investigating Serious Adverse Drug Reactions in Patients Receiving Erythropoiesis-Stimulating Agents: A Root Cause Analysis Using the "ANTICIPATE" Framework. Am J Ther. 2018 Nov/Dec; 25(6):e670-e674.
Score: 0.024
-
Why Biologics and Biosimilars Remain So Expensive: Despite Two Wins for Biosimilars, the Supreme Court's Recent Rulings do not Solve Fundamental Barriers to Competition. Drugs. 2018 Nov; 78(17):1777-1781.
Score: 0.024
-
Fluoroquinolone-associated suicide. Eur J Intern Med. 2018 09; 55:e21-e22.
Score: 0.024
-
Thalidomide, Drug Safety, and Off-label Prescribing: Lessons Learned From Celgene's Settlement. JAMA Oncol. 2018 07 01; 4(7):915-916.
Score: 0.024
-
Editorial Comment. Urology. 2018 08; 118:125-126.
Score: 0.023
-
Biosimilars-Curb Your Enthusiasm. JAMA Oncol. 2017 11 01; 3(11):1467-1468.
Score: 0.023
-
Challenges to Biosimilar Substitution. JAMA. 2017 09 26; 318(12):1186.
Score: 0.022
-
Reply to A.M. Zeidan et al. J Clin Oncol. 2017 10 01; 35(28):3265.
Score: 0.022
-
Improving the Evidence Base for Delivery of High-Quality Cancer Care. JAMA Oncol. 2017 08 01; 3(8):1029-1031.
Score: 0.022
-
Melanoma complicating treatment with natalizumab for multiple sclerosis: A report from the Southern Network on Adverse Reactions (SONAR). Cancer Med. 2017 Jul; 6(7):1541-1551.
Score: 0.022
-
Tale of Two Erythropoiesis-Stimulating Agents: Utilization, Dosing, Litigation, and Costs of Darbepoetin and Epoetin Among South Carolina Medicaid-Covered Patients With Cancer and Chemotherapy-Induced Anemia. J Oncol Pract. 2017 06; 13(6):e562-e573.
Score: 0.022
-
What Have Patients Been Hearing From Providers Since the 2012 USPSTF Recommendation Against Routine Prostate Cancer Screening? Clin Genitourin Cancer. 2017 12; 15(6):e977-e985.
Score: 0.022
-
Why California's Proposition 61 Was a Bad Idea. Am J Med. 2017 08; 130(8):882-884.
Score: 0.022
-
Effects of the US Food and Drug Administration Boxed Warning of Erythropoietin-Stimulating Agents on Utilization and Adverse Outcome. J Clin Oncol. 2017 Jun 10; 35(17):1945-1951.
Score: 0.022
-
Biosimilar and generic cancer drugs unlikely to bend cost curve in the USA. Lancet Oncol. 2017 01; 18(1):22-23.
Score: 0.021
-
Generic oncology drugs: are they all safe? Lancet Oncol. 2016 Nov; 17(11):e493-e501.
Score: 0.021
-
Federal 340B Program Payment Scheme for Drugs Designated As Orphan Products: Congressional Clarification Needed to Close the Government-Industry Revolving Door. J Clin Oncol. 2016 12 20; 34(36):4320-4322.
Score: 0.021
-
Progressive multi-focal leucoencephalopathy among ibrutinib-treated persons with chronic lymphocytic leukaemia. Br J Haematol. 2018 01; 180(2):301-304.
Score: 0.021
-
Detection of cases of progressive multifocal leukoencephalopathy associated with new biologicals and targeted cancer therapies from the FDA's adverse event reporting system. Expert Opin Drug Saf. 2016 Aug; 15(8):1003-11.
Score: 0.020
-
Time course and predictors of use of erectile dysfunction treatment in a Veterans Affairs medical center. Int J Impot Res. 2016 Sep; 28(5):167-71.
Score: 0.020
-
Petitioning the FDA to Improve Pharmaceutical, Device and Public Health Safety by Ordinary Citizens: A Descriptive Analysis. PLoS One. 2016; 11(5):e0155259.
Score: 0.020
-
Racial differences in receipt of adjuvant hormonal therapy among Medicaid enrollees in South Carolina diagnosed with breast cancer. Breast Cancer Res Treat. 2016 05; 157(1):193-200.
Score: 0.020
-
FDA Approval of Extended-Release Oxycodone for Children With Severe Pain. Pediatrics. 2016 05; 137(5).
Score: 0.020
-
Thrombotic thrombocytopenic purpura: gaining knowledge. Lancet Haematol. 2016 05; 3(5):e210-1.
Score: 0.020
-
Relationship of Industry Sponsorship to Results of Cost-Effectiveness Analyses of Drugs Used in Breast Cancer Treatment--Reply. JAMA Oncol. 2016 Apr; 2(4):549.
Score: 0.020
-
Single- versus multiple-tablet HIV regimens: adherence and hospitalization risks. Am J Manag Care. 2016 04; 22(4):242-8.
Score: 0.020
-
Evaluation of gemtuzumab ozogamycin associated sinusoidal obstructive syndrome: Findings from an academic pharmacovigilance program review and a pharmaceutical sponsored registry. Leuk Res. 2016 May; 44:61-4.
Score: 0.020
-
Associations Between Industry Sponsorship and Results of Cost-effectiveness Analyses of Drugs Used in Breast Cancer Treatment. JAMA Oncol. 2016 Feb; 2(2):274-6.
Score: 0.020
-
Big data, thromboembolism, and immunoglobulin. Blood. 2016 Jan 14; 127(2):171-2.
Score: 0.020
-
Consensus on the Existence of Functional Erythropoietin Receptors on Cancer Cells. JAMA Oncol. 2016 Jan; 2(1):134-6.
Score: 0.020
-
Risk factors and impact of non-Aspergillus mold infections following allogeneic HCT: a CIBMTR infection and immune reconstitution analysis. Bone Marrow Transplant. 2016 Feb; 51(2):277-82.
Score: 0.020
-
Is Intravenous Iron Supplementation Safe to Administer to Patients on Hemodialysis with Active Infection--What Do We Know, and What More Do We Need to Know? Clin J Am Soc Nephrol. 2015 Oct 07; 10(10):1714-5.
Score: 0.019
-
Fluoroquinolone-associated tendon-rupture: a summary of reports in the Food and Drug Administration's adverse event reporting system. Expert Opin Drug Saf. 2015; 14(11):1653-60.
Score: 0.019
-
Screening for viral hepatitis prior to rituximab chemotherapy. Ann Hematol. 2016 Jan; 95(1):27-33.
Score: 0.019
-
Adding Bevacizumab to the Treatment of Patients With Non-Small-Cell Lung Cancer: Caveat Emptor. J Oncol Pract. 2015 Sep; 11(5):363-4.
Score: 0.019
-
"Right-to-Try" Legislation: Progress or Peril? J Clin Oncol. 2015 Aug 20; 33(24):2597-9.
Score: 0.019
-
Population-Based Assessment of Determining Treatments for Prostate Cancer. JAMA Oncol. 2015 Apr; 1(1):67-8.
Score: 0.019
-
Japanese regulatory authority's perspective on biosimilars - authors' reply. Lancet Oncol. 2015 Mar; 16(3):e102.
Score: 0.019
-
Editorial comment. Urology. 2015 Feb; 85(2):413.
Score: 0.019
-
Geography: an increasingly important variable in prostate cancer clinical trials. BJU Int. 2015 Jan; 115(1):2-3.
Score: 0.019
-
Cardiac risks associated with antibiotics: azithromycin and levofloxacin. Expert Opin Drug Saf. 2015 Feb; 14(2):295-303.
Score: 0.018
-
Regulatory and clinical considerations for biosimilar oncology drugs. Lancet Oncol. 2014 Dec; 15(13):e594-e605.
Score: 0.018
-
Editorial comment. Urology. 2014 Nov; 84(5):1072.
Score: 0.018
-
Editorial comment. Urology. 2015 Jan; 85(1):153-4.
Score: 0.018
-
Toxicity and costs of toxicity associated with new cancer drugs: international implications. J Clin Oncol. 2014 Nov 10; 32(32):3591-2.
Score: 0.018
-
Reply to magnetic resonance imaging-based diagnosis of progressive multifocal leukoencephalopathy in a patient with non-Hodgkin lymphoma after therapy with cyclophosphamide, doxorubicin, vincristine, prednisone, and rituximab. Cancer. 2014 Dec 15; 120(24):4006-7.
Score: 0.018
-
Erythropoiesis-stimulating agents and quality of life: personal journeys of a cancer survivor, oncologist, and two cancer health services researchers. Br J Cancer. 2014 Jul 29; 111(3):421-3.
Score: 0.018
-
Anaphylaxis and hypotension after administration of peginesatide. N Engl J Med. 2014 May 22; 370(21):2055-6.
Score: 0.018
-
Progressive multifocal leukoencephalopathy associated with brentuximab vedotin therapy: a report of 5 cases from the Southern Network on Adverse Reactions (SONAR) project. Cancer. 2014 Aug 15; 120(16):2464-71.
Score: 0.018
-
Editorial comment. Urology. 2014 Apr; 83(4):786-7.
Score: 0.018
-
Selection of contraceptive therapy for patients with thrombophilia: a review of the evidence. J Womens Health (Larchmt). 2014 Apr; 23(4):318-26.
Score: 0.017
-
Reply to W. Read. J Clin Oncol. 2014 Feb 20; 32(6):604-5.
Score: 0.017
-
Editorial comment. Urology. 2014 Jan; 83(1):152-3; discussion 153.
Score: 0.017
-
Emerging drugs for treatment of anemia of chronic kidney disease. Expert Opin Emerg Drugs. 2013 Dec; 18(4):421-9.
Score: 0.017
-
Forewarned is forearmed: erythropoietin use in CKD patients with cancer. J Nephrol. 2013 Sep-Oct; 26(5):805-6.
Score: 0.017
-
Finishing the picture: problems with public reporting of clinical trials. J Clin Oncol. 2013 Aug 20; 31(24):2981-2.
Score: 0.017
-
Primary prophylaxis with hematopoietic colony stimulating factor: insights from a Canadian cost-effectiveness analysis. J Natl Cancer Inst. 2013 Aug 07; 105(15):1072-3.
Score: 0.017
-
Colony-stimulating factors for febrile neutropenia. N Engl J Med. 2013 07 18; 369(3):286.
Score: 0.017
-
Editorial comment. Urology. 2013 Jul; 82(1):66.
Score: 0.017
-
Vision insurance, eye care visits, and vision impairment among working-age adults in the United States. JAMA Ophthalmol. 2013 Apr; 131(4):499-506.
Score: 0.016
-
Ticlopidine-associated ADAMTS13 activity deficient thrombotic thrombocytopenic purpura in 22 persons in Japan: a report from the Southern Network on Adverse Reactions (SONAR). Br J Haematol. 2013 Jun; 161(6):896-8.
Score: 0.016
-
Colony-stimulating factors for febrile neutropenia during cancer therapy. N Engl J Med. 2013 Mar 21; 368(12):1131-9.
Score: 0.016
-
Tackling community-acquired methicillin-resistant Staphylococcus aureus in collegiate football players following implementation of an anti-MRSA programme. Br J Sports Med. 2014 Feb; 48(4):284-5.
Score: 0.016
-
Editorial comment. Urology. 2013 Jan; 81(1):154; author reply 154.
Score: 0.016
-
Mind the gap: racial differences in breast cancer incidence and biologic phenotype, but not stage, among low-income women participating in a government-funded screening program. Breast Cancer Res Treat. 2013 Jan; 137(2):589-98.
Score: 0.016
-
Will newer anticoagulants improve therapy persistence? Arch Intern Med. 2012 Nov 26; 172(21):1689-90.
Score: 0.016
-
Adverse effects of drugs on hemostasis and thrombosis. Semin Thromb Hemost. 2012 Nov; 38(8):755-8.
Score: 0.016
-
A review of safety, efficacy, and utilization of erythropoietin, darbepoetin, and peginesatide for patients with cancer or chronic kidney disease: a report from the Southern Network on Adverse Reactions (SONAR). Semin Thromb Hemost. 2012 Nov; 38(8):783-96.
Score: 0.016
-
Ticlopidine-, clopidogrel-, and prasugrel-associated thrombotic thrombocytopenic purpura: a 20-year review from the Southern Network on Adverse Reactions (SONAR). Semin Thromb Hemost. 2012 Nov; 38(8):845-53.
Score: 0.016
-
Thromboprophylaxis guidelines in cancer with a primary focus on ambulatory patients receiving chemotherapy: a review from the Southern Network on Adverse Reactions (SONAR). Semin Thromb Hemost. 2012 Nov; 38(8):759-67.
Score: 0.016
-
Underreporting of hemorrhagic and thrombotic complications of pharmaceuticals to the U.S. Food and Drug Administration: empirical findings for warfarin, clopidogrel, ticlopidine, and thalidomide from the Southern Network on Adverse Reactions (SONAR). Semin Thromb Hemost. 2012 Nov; 38(8):905-7.
Score: 0.016
-
Six years after. Acta Radiol. 2012 Oct 01; 53(8):827-9.
Score: 0.016
-
Epidemiologic methods lessons learned from environmental public health disasters: Chernobyl, the World Trade Center, Bhopal, and Graniteville, South Carolina. Int J Environ Res Public Health. 2012 08; 9(8):2894-909.
Score: 0.016
-
A tale of two citizens: a State Attorney General and a hematologist facilitate translation of research into US Food and Drug Administration actions--a SONAR report. J Oncol Pract. 2012 Nov; 8(6):e158-67.
Score: 0.016
-
Editorial comment. Urology. 2012 Sep; 80(3):563.
Score: 0.016
-
Linking drugs to obscure illnesses: lessons from pure red cell aplasia, nephrogenic systemic fibrosis, and Reye's syndrome. a report from the Southern Network on Adverse Reactions (SONAR). J Gen Intern Med. 2012 Dec; 27(12):1697-703.
Score: 0.016
-
Editorial comment. Urology. 2012 Jul; 80(1):168.
Score: 0.015
-
A 56-year-old physician who underwent a PSA test. Arch Intern Med. 2012 Feb 27; 172(4):311.
Score: 0.015
-
Pharmacovigilance and PML in the oncology setting. Cleve Clin J Med. 2011 Nov; 78 Suppl 2:S13-7.
Score: 0.015
-
Pharmaceutical fraud and abuse in the United States, 1996-2010. Arch Intern Med. 2011 Sep 12; 171(16):1503-6.
Score: 0.015
-
Description of anaphylactic reactions to paclitaxel and docetaxel reported to the FDA, with a focus on the role of premedication. Expert Opin Drug Saf. 2011 Jul; 10(4):521-8.
Score: 0.014
-
Enforcement actions involving Medicaid fraud and abuse, 1996-2009. Arch Intern Med. 2011 Apr 25; 171(8):785-7.
Score: 0.014
-
Epileptogenic potential of carbapenem agents: mechanism of action, seizure rates, and clinical considerations. Pharmacotherapy. 2011 Apr; 31(4):408-23.
Score: 0.014
-
Nighttime and weekend medication error rates in an inpatient pediatric population. Ann Pharmacother. 2010 Nov; 44(11):1739-46.
Score: 0.014
-
Association between pharmaceutical support and basic science research on erythropoiesis-stimulating agents. Arch Intern Med. 2010 Sep 13; 170(16):1490-8.
Score: 0.014
-
Invited commentary: Prostate cancer: doing less might be more. Comment on "Severity of comorbidity and non-prostate cancer mortality in men with early-stage prostate cancer". Arch Intern Med. 2010 Aug 09; 170(15):1397-9.
Score: 0.014
-
The excessive cost of early stage bladder cancer care: are providers really to blame? Cancer. 2010 Aug 01; 116(15):3530-2.
Score: 0.014
-
Surgery and adjuvant chemotherapy use among veterans with colon cancer: insights from a California study. J Clin Oncol. 2010 May 20; 28(15):2571-6.
Score: 0.013
-
Reassessments of ESAs for cancer treatment in the US and Europe. Oncology (Williston Park). 2010 Mar; 24(3):260-8.
Score: 0.013
-
Racial variations in care and outcomes for inpatient HIV-related pneumocystis pneumonia. J Health Care Poor Underserved. 2010 Feb; 21(1):318-33.
Score: 0.013
-
Adverse drug interactions: moving from perception to action. Pharmacoeconomics. 2010; 28(1):19-22.
Score: 0.013
-
Czech health two decades on from the Velvet Revolution. Lancet. 2010 Jan 16; 375(9710):179-81.
Score: 0.013
-
Monoclonal antibody-associated progressive multifocal leucoencephalopathy in patients treated with rituximab, natalizumab, and efalizumab: a Review from the Research on Adverse Drug Events and Reports (RADAR) Project. Lancet Oncol. 2009 Aug; 10(8):816-24.
Score: 0.013
-
Accelerated approval of cancer drugs: improved access to therapeutic breakthroughs or early release of unsafe and ineffective drugs? J Clin Oncol. 2009 Sep 10; 27(26):4398-405.
Score: 0.013
-
Partnering to promote equality in cancer care. Soc Work Public Health. 2009 Jul-Aug; 24(4):355-9.
Score: 0.013
-
Upping recruitment in clinical trials: are the costs worth it? Onkologie. 2009 Jul; 32(7):378-9.
Score: 0.013
-
Metastasis of genitourinary tumors to the head and neck region. Eur Arch Otorhinolaryngol. 2010 Feb; 267(2):273-9.
Score: 0.013
-
Quality of reporting of serious adverse drug events to an institutional review board: a case study with the novel cancer agent, imatinib mesylate. Clin Cancer Res. 2009 Jun 01; 15(11):3850-5.
Score: 0.013
-
Providing cancer care to a graying and diverse cancer population in the 21st century: are we prepared? J Clin Oncol. 2009 Jun 10; 27(17):2745-6.
Score: 0.012
-
Heeding our words: complexities of research among low-literacy populations. J Clin Oncol. 2009 Apr 20; 27(12):1938-40.
Score: 0.012
-
Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project. Blood. 2009 May 14; 113(20):4834-40.
Score: 0.012
-
Rituximab and progressive multi-focal leukoencephalopathy: the jury is deliberating. Leuk Lymphoma. 2009 Mar; 50(3):323-4.
Score: 0.012
-
Proxy assessment of health-related quality of life in african american and white respondents with prostate cancer: perspective matters. Med Care. 2009 Feb; 47(2):176-83.
Score: 0.012
-
Ticlopidine- and clopidogrel-associated thrombotic thrombocytopenic purpura (TTP): review of clinical, laboratory, epidemiological, and pharmacovigilance findings (1989-2008). Kidney Int Suppl. 2009 Feb; (112):S20-4.
Score: 0.012
-
Intersecting guidelines: administering erythropoiesis-stimulating agents to chronic kidney disease patients with cancer. Semin Dial. 2009 Jan-Feb; 22(1):1-4.
Score: 0.012
-
Pharmacovigilance and reporting oversight in US FDA fast-track process: bisphosphonates and osteonecrosis of the jaw. Lancet Oncol. 2008 Dec; 9(12):1166-72.
Score: 0.012
-
Evaluating the supportive care costs of severe radiochemotherapy-induced mucositis and pharyngitis : results from a Northwestern University Costs of Cancer Program pilot study with head and neck and nonsmall cell lung cancer patients who received care at a county hospital, a Veterans Administration hospital, or a comprehensive cancer care center. Cancer. 2008 Sep 15; 113(6):1446-52.
Score: 0.012
-
Late-onset hereditary axonal neuropathies. Neurology. 2008 Jul 01; 71(1):14-20.
Score: 0.012
-
Epoetin-associated pure red cell aplasia: past, present, and future considerations. Transfusion. 2008 Aug; 48(8):1754-62.
Score: 0.012
-
Non-Hodgkins lymphoma: how well you do may depend on where you live. Leuk Lymphoma. 2008 May; 49(5):841-2.
Score: 0.012
-
Treatment success in cancer: new cancer treatment successes identified in phase 3 randomized controlled trials conducted by the National Cancer Institute-sponsored cooperative oncology groups, 1955 to 2006. Arch Intern Med. 2008 Mar 24; 168(6):632-42.
Score: 0.012
-
Venous thromboembolism and mortality associated with recombinant erythropoietin and darbepoetin administration for the treatment of cancer-associated anemia. JAMA. 2008 Feb 27; 299(8):914-24.
Score: 0.012
-
Does reimbursement affect physicians' decision making? Examples from the use of recombinant erythropoietin. Cancer Treat Res. 2008; 140:235-51.
Score: 0.011
-
Two mechanistic pathways for thienopyridine-associated thrombotic thrombocytopenic purpura: a report from the SERF-TTP Research Group and the RADAR Project. J Am Coll Cardiol. 2007 Sep 18; 50(12):1138-43.
Score: 0.011
-
The sound and the fury: financial conflicts of interest in oncology. J Clin Oncol. 2007 Aug 20; 25(24):3567-9.
Score: 0.011
-
Legal, financial, and public health consequences of transfusion-transmitted hepatitis C virus in persons with haemophilia. Vox Sang. 2007 Aug; 93(2):159-65.
Score: 0.011
-
Cancer-associated neutropenic fever: clinical outcome and economic costs of emergency department care. Oncologist. 2007 Aug; 12(8):1019-26.
Score: 0.011
-
Process evaluation in an intervention designed to improve rates of colorectal cancer screening in a VA medical center. Health Promot Pract. 2007 Jul; 8(3):273-81.
Score: 0.011
-
Granulocyte-colony stimulating factor administration to healthy individuals and persons with chronic neutropenia or cancer: an overview of safety considerations from the Research on Adverse Drug Events and Reports project. Bone Marrow Transplant. 2007 Aug; 40(3):185-92.
Score: 0.011
-
Adverse effects of drugs used to treat hematologic malignancies: surveillance efforts from the research on adverse drug events and reports project. Semin Thromb Hemost. 2007 Jun; 33(4):365-72.
Score: 0.011
-
Cost considerations in the management of cancer in the older patient. Oncology (Williston Park). 2007 Jun; 21(7):851-7; discussion 858, 860, 862 passim.
Score: 0.011
-
Evaluation of serious adverse drug reactions: a proactive pharmacovigilance program (RADAR) vs safety activities conducted by the Food and Drug Administration and pharmaceutical manufacturers. Arch Intern Med. 2007 May 28; 167(10):1041-9.
Score: 0.011
-
Responding to a small-scale bioterrorist anthrax attack: cost-effectiveness analysis comparing preattack vaccination with postattack antibiotic treatment and vaccination. Arch Intern Med. 2007 Apr 09; 167(7):655-62.
Score: 0.011
-
Evaluating the total costs of chemotherapy-induced febrile neutropenia: results from a pilot study with community oncology cancer patients. Oncologist. 2007 Apr; 12(4):478-83.
Score: 0.011
-
Discriminating inhalational anthrax from community-acquired pneumonia using chest radiograph findings and a clinical algorithm. Chest. 2007 Feb; 131(2):489-96.
Score: 0.011
-
Systematic review of piperacillin-induced neutropenia. Drug Saf. 2007; 30(4):295-306.
Score: 0.011
-
Thalidomide- and lenalidomide-associated thromboembolism among patients with cancer. JAMA. 2006 Dec 06; 296(21):2558-60.
Score: 0.011
-
In cis autosomal dominant mutation of Senataxin associated with tremor/ataxia syndrome. Neurogenetics. 2007 Jan; 8(1):45-9.
Score: 0.011
-
Haematological malignancies developing in previously healthy individuals who received haematopoietic growth factors: report from the Research on Adverse Drug Events and Reports (RADAR) project. Br J Haematol. 2006 Dec; 135(5):642-50.
Score: 0.010
-
Literacy, race, and PSA level among low-income men newly diagnosed with prostate cancer. Urology. 2006 Jul; 68(1):89-93.
Score: 0.010
-
When the risk of febrile neutropenia is 20%, prophylactic colony-stimulating factor use is clinically effective, but is it cost-effective? J Clin Oncol. 2006 Jul 01; 24(19):2975-7.
Score: 0.010
-
Clinical features and correlates of gemcitabine-associated lung injury: findings from the RADAR project. Cancer. 2006 May 01; 106(9):2051-7.
Score: 0.010
-
Local perspective of the impact of the HIPAA privacy rule on research. Cancer. 2006 Jan 15; 106(2):474-9.
Score: 0.010
-
Reducing adverse drug events in the outpatient chemotherapy setting: attention must be paid. Cancer. 2005 Dec 01; 104(11):2289-91.
Score: 0.010
-
Costs and cost effectiveness of a health care provider-directed intervention to promote colorectal cancer screening among Veterans. J Clin Oncol. 2005 Dec 01; 23(34):8877-83.
Score: 0.010
-
Caveat medicus: consequences of federal investigations of marketing activities of pharmaceutical suppliers of prostate cancer drugs. J Clin Oncol. 2005 Dec 01; 23(34):8894-905.
Score: 0.010
-
Thrombotic thrombocytopenic purpura-2005. Semin Thromb Hemost. 2005 Dec; 31(6):611-4.
Score: 0.010
-
Drug-induced thrombotic microangiopathy. Semin Thromb Hemost. 2005 Dec; 31(6):681-90.
Score: 0.010
-
Relation between literacy and HIV treatment knowledge among patients on HAART regimens. AIDS Care. 2005 Oct; 17(7):863-73.
Score: 0.010
-
Acting on imperfect evidence: How much regret are we ready to accept? J Clin Oncol. 2005 Oct 01; 23(28):6822-5.
Score: 0.010
-
Long-term outcome of individuals with pure red cell aplasia and antierythropoietin antibodies in patients treated with recombinant epoetin: a follow-up report from the Research on Adverse Drug Events and Reports (RADAR) Project. Blood. 2005 Nov 15; 106(10):3343-7.
Score: 0.010
-
Opportunities for disease state management in prostate cancer. Dis Manag. 2005 Aug; 8(4):235-44.
Score: 0.010
-
Colorectal cancer screening among African-American and white male veterans. Am J Prev Med. 2005 Jun; 28(5):479-82.
Score: 0.010
-
Low-molecular-weight heparins: do we have the GUSTO to identify differences between alternative formulations? Arch Intern Med. 2005 Apr 11; 165(7):722-3.
Score: 0.009
-
Health care provider-directed intervention to increase colorectal cancer screening among veterans: results of a randomized controlled trial. J Clin Oncol. 2005 Mar 01; 23(7):1548-54.
Score: 0.009
-
Delays in suspicion and isolation among hospitalized persons with pulmonary tuberculosis at public and private US hospitals during 1996 to 1999. Chest. 2005 Jan; 127(1):205-12.
Score: 0.009
-
The blue cross blue shield assessment technology review: summary of findings. Best Pract Res Clin Haematol. 2005; 18(3):423-31.
Score: 0.009
-
Effectiveness of erythropoietin in the treatment of patients with malignancies: methods and preliminary results of a Cochrane review. Best Pract Res Clin Haematol. 2005; 18(3):449-54.
Score: 0.009
-
Granulocyte colony--stimulating factor for chemotherapy-induced neutropenia in patients with small cell lung cancer : the 40% rule revisited. Pharmacoeconomics. 2005; 23(8):767-75.
Score: 0.009
-
Pharmacoeconomics of liposomal anthracycline therapy. Semin Oncol. 2004 Dec; 31(6 Suppl 13):191-5.
Score: 0.009
-
Health literacy and patient knowledge in a Southern US HIV clinic. Int J STD AIDS. 2004 Nov; 15(11):747-52.
Score: 0.009
-
Pure red-cell aplasia and epoetin therapy. N Engl J Med. 2004 Sep 30; 351(14):1403-8.
Score: 0.009
-
Estimating the cost of cancer: results on the basis of claims data analyses for cancer patients diagnosed with seven types of cancer during 1999 to 2000. J Clin Oncol. 2004 Sep 01; 22(17):3524-30.
Score: 0.009
-
Colorectal cancer screening knowledge, attitudes, and beliefs among veterans: does literacy make a difference? J Clin Oncol. 2004 Jul 01; 22(13):2617-22.
Score: 0.009
-
Agreement between prostate cancer patients and their clinicians about utilities and attribute importance. Health Expect. 2004 Jun; 7(2):115-25.
Score: 0.009
-
Ethnic variation in localized prostate cancer: a pilot study of preferences, optimism, and quality of life among black and white veterans. Clin Prostate Cancer. 2004 Jun; 3(1):31-7.
Score: 0.009
-
The financial burden of cancer: estimates from a study of insured women with breast cancer. J Support Oncol. 2004 May-Jun; 2(3):271-8.
Score: 0.009
-
A comparison of ovarian cancer treatments: analysis of utility assessments of ovarian cancer patients, at-risk population, general population, and physicians. Gynecol Oncol. 2004 Apr; 93(1):164-9.
Score: 0.009
-
Serious adverse cutaneous and hepatic toxicities associated with nevirapine use by non-HIV-infected individuals. J Acquir Immune Defic Syndr. 2004 Feb 01; 35(2):120-5.
Score: 0.009
-
US hospital care for patients with HIV infection and pneumonia: the role of public, private, and Veterans Affairs hospitals in the early highly active antiretroviral therapy era. Chest. 2004 Feb; 125(2):548-56.
Score: 0.009
-
Clopidogrel-associated TTP: an update of pharmacovigilance efforts conducted by independent researchers, pharmaceutical suppliers, and the Food and Drug Administration. Stroke. 2004 Feb; 35(2):533-7.
Score: 0.009
-
Use of erythropoietin in cancer patients: assessment of oncologists' practice patterns in the United States and other countries. Am J Med. 2004 Jan 01; 116(1):28-34.
Score: 0.009
-
Relationship between health insurance and medical care for patients hospitalized with human immunodeficiency virus-related Pneumocystis carinii pneumonia, 1995-1997: Medicaid, bronchoscopy, and survival. Clin Infect Dis. 2003 Dec 01; 37(11):1549-55.
Score: 0.009
-
Cost analyses of granulocyte colony stimulating factor: a focus on older patients with cancer. Crit Rev Oncol Hematol. 2003 Oct 15; 48(Suppl):S71-4.
Score: 0.009
-
Perspectives on the value of American Society of Clinical Oncology clinical guidelines as reported by oncologists and health maintenance organizations. J Clin Oncol. 2003 Mar 01; 21(5):937-41.
Score: 0.008
-
Evaluating the total costs of cancer. The Northwestern University Costs of Cancer Program. Oncology (Williston Park). 2003 Jan; 17(1):109-14; discussion 119-21.
Score: 0.008
-
Cost analyses of adjunct colony stimulating factors for older patients with acute myeloid leukaemia : can they improve clinical decision making? Drugs Aging. 2003; 20(7):479-83.
Score: 0.008
-
Hepatotoxicity after prophylaxis with a nevirapine-containing antiretroviral regimen. Ann Intern Med. 2002 Jul 16; 137(2):146-7.
Score: 0.008
-
Cost-effectiveness considerations in the treatment of essential thrombocythemia. Semin Oncol. 2002 Jun; 29(3 Suppl 10):28-32.
Score: 0.008
-
Medicare Spending on Drugs With Accelerated Approval. Ann Intern Med. 2022 07; 175(7):938-944.
Score: 0.008
-
Pharmacoeconomics of therapy for ITP: steroids, i.v.Ig, anti-D, and splenectomy. Blood Rev. 2002 Mar; 16(1):65-7.
Score: 0.008
-
Single-arm clinical trials that supported FDA accelerated approvals have modest effect sizes and were at high risk of bias. J Clin Epidemiol. 2022 08; 148:193-195.
Score: 0.008
-
A New Criterion for Fluoroquinolone-Associated Disability Diagnosis: Functional Gastrointestinal Disorders. Medicina (Kaunas). 2021 Dec 16; 57(12).
Score: 0.007
-
Clinical trials: are they a good buy? J Clin Oncol. 2001 Dec 01; 19(23):4330-9.
Score: 0.007
-
Mogamulizumab efficacy is underscored by its associated rash that mimics cutaneous T-cell lymphoma: a retrospective single-centre case series. Br J Dermatol. 2022 01; 186(1):153-166.
Score: 0.007
-
HIV-related Pneumocystis carinii pneumonia in older patients hospitalized in the early HAART era. J Gen Intern Med. 2001 Sep; 16(9):583-9.
Score: 0.007
-
Comparison and impact of COVID-19 for patients with cancer: a survival analysis of fatality rate controlling for age, sex and cancer type. BMJ Health Care Inform. 2021 May; 28(1).
Score: 0.007
-
A spatial assessment of prostate cancer mortality-to-incidence ratios among South Carolina veterans: 1999-2015. Ann Epidemiol. 2021 07; 59:24-32.
Score: 0.007
-
Prospective comparison of stereotactic core biopsy and surgical excision as diagnostic procedures for breast cancer patients. Ann Surg. 2001 Apr; 233(4):537-41.
Score: 0.007
-
Combined androgen blockade with nonsteroidal antiandrogens for advanced prostate cancer: a systematic review. Urology. 2001 Apr; 57(4):727-32.
Score: 0.007
-
Variations in institutional review board decisions for HIV quality of care studies: a potential source of study bias. J Acquir Immune Defic Syndr. 2001 Apr 01; 26(4):390-1.
Score: 0.007
-
Cytoplasmic synthesis of endogenous Alu complementary DNA via reverse transcription and implications in age-related macular degeneration. Proc Natl Acad Sci U S A. 2021 02 09; 118(6).
Score: 0.007
-
Spouse ratings of quality of life in patients with metastatic prostate cancer of lower socioeconomic status: an assessment of feasibility, reliability, and validity. Urology. 2001 Feb; 57(2):275-80.
Score: 0.007
-
HIV and AIDS: an overview. Nurs Stand. 2001 Feb 28-Mar 6; 15(24):45-52; quiz 54-5.
Score: 0.007
-
Initial Management of Noncastrate Advanced, Recurrent, or Metastatic Prostate Cancer: ASCO Guideline Update. J Clin Oncol. 2021 04 10; 39(11):1274-1305.
Score: 0.007
-
Economic analysis of amifostine as adjunctive support for patients with advanced head and neck cancer: preliminary results from a randomized phase II clinical trial from Germany. Cancer Invest. 2001; 19(2):107-13.
Score: 0.007
-
The role of inadequate health literacy skills in colorectal cancer screening. Cancer Invest. 2001; 19(2):193-200.
Score: 0.007
-
Improving rates of cervical cancer screening and Pap smear follow-up for low-income women with limited health literacy. Cancer Invest. 2001; 19(3):316-23.
Score: 0.007
-
Do radiation oncologists and urologists endorse decision aids for active surveillance of low-risk prostate cancer: Results from a national survey. Eur J Cancer Care (Engl). 2021 Jan; 30(1):e13301.
Score: 0.007
-
Health care in Hong Kong and mainland China: one country, two systems? Health Policy. 2000 Oct; 53(3):147-55.
Score: 0.007
-
Repurposing anti-inflammasome NRTIs for improving insulin sensitivity and reducing type 2 diabetes development. Nat Commun. 2020 09 23; 11(1):4737.
Score: 0.007
-
Hospital measures for prevention of tuberculosis transmission in U.S. cities with and without previous nosocomial tuberculosis outbreaks. Ann Intern Med. 2000 Sep 19; 133(6):486.
Score: 0.007
-
Evaluating the financial impact of clinical trials in oncology: results from a pilot study from the Association of American Cancer Institutes/Northwestern University clinical trials costs and charges project. J Clin Oncol. 2000 Aug; 18(15):2805-10.
Score: 0.007
-
Improvements in outcomes of acute respiratory failure for patients with human immunodeficiency virus-related Pneumocystis carinii pneumonia. Am J Respir Crit Care Med. 2000 Aug; 162(2 Pt 1):393-8.
Score: 0.007
-
Response to: letter to the editor: consideration on 'an evaluation of reports of ciprofloxacin, levofloxacin, and moxifloxacin association neuropsychiatric toxicities, long-term disability, and aortic aneurysms/dissections disseminated by the food and drug administration and the European medicines agency' by bennett et al. Expert Opin Drug Saf. 2020 08; 19(8):1057-1058.
Score: 0.007
-
Thrombotic thrombocytopenic purpura associated with clopidogrel. N Engl J Med. 2000 Jun 15; 342(24):1773-7.
Score: 0.007
-
A new preadmission staging system for predicting inpatient mortality from HIV-associated Pneumocystis carinii pneumonia in the early highly active antiretroviral therapy (HAART) era. Am J Respir Crit Care Med. 2000 Apr; 161(4 Pt 1):1081-6.
Score: 0.007
-
Cost analyses of adjunct colony stimulating factors for acute leukemia: can they improve clinical decision making. Leuk Lymphoma. 2000 Mar; 37(1-2):65-70.
Score: 0.007
-
Operation Safe Haven: an evaluation of health surveillance and monitoring in an acute setting. Commun Dis Intell. 2000 Feb 17; 24(2):21-6.
Score: 0.007
-
Cost analysis of filgrastim for the prevention of neutropenia in pediatric T-cell leukemia and advanced lymphoblastic lymphoma: a case for prospective economic analysis in cooperative group trials. Med Pediatr Oncol. 2000 Feb; 34(2):92-6.
Score: 0.007
-
Patient- and area-level predictors of prostate cancer among South Carolina veterans: a spatial analysis. Cancer Causes Control. 2020 Mar; 31(3):209-220.
Score: 0.007
-
Does reimbursement affect physician decision making? Cancer Treat Res. 2000; 102:137-49.
Score: 0.007
-
The potential for treatment of idiopathic thrombocytopenic purpura with anti-D to prevent splenectomy: a predictive cost analysis. Semin Hematol. 2000 Jan; 37(1 Suppl 1):26-30.
Score: 0.007
-
Comparing cost-effectiveness analyses for the clinical oncology setting: the example of the Gynecologic Oncology Group 111 trial. Cancer Invest. 2000; 18(3):261-8.
Score: 0.007
-
Quality improvement: carrots or sticks? J Clin Oncol. 1999 Dec; 17(12):3856-60.
Score: 0.007
-
Thrombotic thrombocytopenic purpura associated with ticlopidine in the setting of coronary artery stents and stroke prevention. Arch Intern Med. 1999 Nov 22; 159(21):2524-8.
Score: 0.006
-
Ticlopidine and TTP after coronary stenting. JAMA. 1999 Nov 10; 282(18):1717; author reply 1718-9.
Score: 0.006
-
Hepatitis B Virus Reactivation: Risk Factors and Current Management Strategies. Pharmacotherapy. 2019 12; 39(12):1190-1203.
Score: 0.006
-
Use of hematopoietic colony-stimulating factors: comparison of the 1994 and 1997 American Society of Clinical Oncology surveys regarding ASCO clinical practice guidelines. Health Services Research Committee of the American Society of Clinical Oncology. J Clin Oncol. 1999 Nov; 17(11):3676-81.
Score: 0.006
-
The association between physician reimbursement in the US and use of hematopoietic colony stimulating factors as adjunct therapy for older patients with acute myeloid leukemia: results from the 1997 American Society of Clinical Oncology survey. Health Services Research Committee of the American Society of Clinical Oncology. Ann Oncol. 1999 Nov; 10(11):1355-9.
Score: 0.006
-
Preparing for refugee crises in Australia: Kosovar health surveillance. Commun Dis Intell. 1999 Oct 28; 23(11):305.
Score: 0.006
-
An evaluation of reports of ciprofloxacin, levofloxacin, and moxifloxacin-association neuropsychiatric toxicities, long-term disability, and aortic aneurysms/dissections disseminated by the Food and Drug Administration and the European Medicines Agency. Expert Opin Drug Saf. 2019 Nov; 18(11):1055-1063.
Score: 0.006
-
Valuing clinical strategies early in development: a cost analysis of allogeneic peripheral blood stem cell transplantation. Bone Marrow Transplant. 1999 Sep; 24(5):555-60.
Score: 0.006
-
Variations in inpatient care for HIV-related tuberculosis patients during a recent nosocomial outbreak of multidrug-resistant tuberculosis. J Acquir Immune Defic Syndr. 1999 Aug 01; 21(4):348-9.
Score: 0.006
-
Quality of life in low-income patients with metastatic prostate cancer: divergent and convergent validity of three instruments. Qual Life Res. 1999 Aug; 8(5):461-70.
Score: 0.006
-
Racial variation in the use of laparoscopic cholecystectomy in the Department of Veterans Affairs medical system. J Am Coll Surg. 1999 Jun; 188(6):604-22.
Score: 0.006
-
The relation between physician experience and patterns of care for patients with AIDS-related Pneumocystis carinii pneumonia: results from a survey of 1,500 physicians in the United States. Chest. 1999 Jun; 115(6):1563-9.
Score: 0.006
-
A multi-attribute model of prostate cancer patient's preferences for health states. Qual Life Res. 1999 May; 8(3):171-80.
Score: 0.006
-
Pharmacoeconomics of amifostine in ovarian cancer. Semin Oncol. 1999 Apr; 26(2 Suppl 7):102-7.
Score: 0.006
-
Diffusion of laparoscopic cholecystectomy in the Veterans Affairs health care system, 1991-1995. Eff Clin Pract. 1999 Mar-Apr; 2(2):49-55.
Score: 0.006
-
The effect of reimbursement policies on the management of Medicare patients with refractory ovarian cancer. Semin Oncol. 1999 Feb; 26(1 Suppl 1):40-5.
Score: 0.006
-
Economic analysis of a randomized placebo-controlled phase III study of granulocyte macrophage colony stimulating factor in adult patients (> 55 to 70 years of age) with acute myelogenous leukemia. Eastern Cooperative Oncology Group (E1490). Ann Oncol. 1999 Feb; 10(2):177-82.
Score: 0.006
-
Identifying providers of care to individuals with human immunodeficiency virus for a mail survey using a prescription tracking database. J Clin Epidemiol. 1999 Feb; 52(2):147-50.
Score: 0.006
-
A national survey of radiation oncologists and urologists on prediction tools and nomograms for localized prostate cancer. World J Urol. 2019 Oct; 37(10):2099-2108.
Score: 0.006
-
Cost-effectiveness model of a phase II clinical trial of a new pharmaceutical for essential thrombocythemia: is it helpful to policy makers? Semin Hematol. 1999 Jan; 36(1 Suppl 2):26-9.
Score: 0.006
-
Growth of oncology physician practice management companies. Cancer Invest. 1999; 17(5):362-70.
Score: 0.006
-
Cost analysis of second-line therapies for platinum-refractory ovarian cancer: reimbursement dilemmas for Medicare patients. Cancer Invest. 1999; 17(8):559-65.
Score: 0.006
-
Cost-effectiveness analysis of pegylated-liposomal doxorubicin and liposomal daunorubicin treatments in patients with Kaposi's sarcoma. Acta Oncol. 1999; 38(8):1063-7.
Score: 0.006
-
A unifying framework for improving health care. J Eval Clin Pract. 2019 Jun; 25(3):358-362.
Score: 0.006
-
Quality of life in metastatic prostate cancer among men of lower socioeconomic status: feasibility and criterion related validity of 3 measures. J Urol. 1998 Nov; 160(5):1765-9.
Score: 0.006
-
Thrombotic thrombocytopenic purpura after stenting and ticlopidine. Lancet. 1998 Sep 26; 352(9133):1036-7.
Score: 0.006
-
Relation between literacy, race, and stage of presentation among low-income patients with prostate cancer. J Clin Oncol. 1998 Sep; 16(9):3101-4.
Score: 0.006
-
The 2018 ISDE achalasia guidelines. Dis Esophagus. 2018 Sep 01; 31(9).
Score: 0.006
-
Cost-effectiveness analysis comparing liposomal anthracyclines in the treatment of AIDS-related Kaposi's sarcoma. J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Aug 15; 18(5):460-5.
Score: 0.006
-
Prostate cancer patients' utilities for health states: how it looks depends on where you stand. Med Decis Making. 1998 Jul-Sep; 18(3):278-86.
Score: 0.006
-
Association Between Androgen Deprivation Therapy and Patient-reported Depression in Men With Recurrent Prostate Cancer. Clin Genitourin Cancer. 2018 08; 16(4):313-317.
Score: 0.006
-
Thrombotic thrombocytopenic purpura associated with ticlopidine. A review of 60 cases. Ann Intern Med. 1998 Apr 01; 128(7):541-4.
Score: 0.006
-
Treating malignant pleural effusions cost consciously. Chest. 1998 Jan; 113(1 Suppl):78S-85S.
Score: 0.006
-
Cancer insurance policies in Japan and the United States. West J Med. 1998 Jan; 168(1):17-22.
Score: 0.006
-
Gender differences in care for acquired immunodeficiency syndrome-related Pneumocystis carinii pneumonia. Womens Health Issues. 1998 Jan-Feb; 8(1):45-52.
Score: 0.006
-
Health economics in the treatment of colorectal cancer. Cancer Invest. 1998; 16(8):582-7.
Score: 0.006
-
Variations in the use of prostate cancer staging tests: results from one NCCN Institution. Oncology (Williston Park). 1997 Nov; 11(11A):155-7.
Score: 0.006
-
Visual coping scenarios to facilitate discussion of coping responses with impoverished women at risk for AIDS. J Psychosoc Nurs Ment Health Serv. 1997 Aug; 35(8):17-23.
Score: 0.006
-
Variations in medical care for HIV-related Pneumocystis carinii pneumonia: a comparison of process and outcome at two hospitals. Chest. 1997 Aug; 112(2):398-405.
Score: 0.006
-
Predicting in-hospital mortality of patients with AIDS-related Pneumocystis carinii pneumonia: an example of hierarchically optimal classification tree analysis. Stat Med. 1997 Jul 15; 16(13):1451-63.
Score: 0.006
-
Implementation of a rapid assay of ADAMTS13 activity was associated with improved 30-day survival rate in patients with acquired primary thrombotic thrombocytopenic purpura who received platelet transfusions. Transfusion. 2017 08; 57(8):2045-2053.
Score: 0.005
-
Gender differences in early suspicion of tuberculosis in hospitalized, high-risk patients during 4 epidemic years, 1987 to 1990. Infect Control Hosp Epidemiol. 1997 Apr; 18(4):237-43.
Score: 0.005
-
Treatment considerations for persons with metastatic prostate cancer: survival versus out-of-pocket costs. Urology. 1997 Feb; 49(2):218-24.
Score: 0.005
-
The learning curve for laparoscopic colorectal surgery. Preliminary results from a prospective analysis of 1194 laparoscopic-assisted colectomies. Arch Surg. 1997 Jan; 132(1):41-4; discussion 45.
Score: 0.005
-
Health care economics and bone marrow transplantation. Cancer Treat Res. 1997; 77:377-99.
Score: 0.005
-
Economic analyses of phase III cooperative cancer group clinical trials: are they feasible? Cancer Invest. 1997; 15(3):227-36.
Score: 0.005
-
A comparison of perspectives on prostate cancer: analysis of utility assessments of patients and physicians. Eur Urol. 1997; 32 Suppl 3:86-8.
Score: 0.005
-
The effect of ethnicity on ICU use and DNR orders in hospitalized AIDS patients. J Clin Ethics. 1997; 8(2):150-7.
Score: 0.005
-
Economic analyses in clinical trials for cooperative groups: operational considerations. Cancer Invest. 1997; 15(5):448-53.
Score: 0.005
-
Interpretation of surrogate endpoints in the era of the 21st Century Cures Act. BMJ. 2016 Dec 30; 355:i6286.
Score: 0.005
-
Geographic variation in the management and outcome of patients with AIDS-related Pneumocystis carinii pneumonia. J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Dec 15; 13(5):408-15.
Score: 0.005
-
U.S. hospital care for HIV-infected persons and the role of public, private, and Veterans Administration hospitals. J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Dec 15; 13(5):416-21.
Score: 0.005
-
Types of oral contraceptives and breast cancer survival among women enrolled in Medicaid: A competing-risk model. Maturitas. 2017 Jan; 95:42-49.
Score: 0.005
-
Patterns of care for HIV-related Pneumocystis carinii pneumonia in a university medical program: a case study. Clin Perform Qual Health Care. 1996 Oct-Dec; 4(4):186-9.
Score: 0.005
-
Use of hematopoietic colony-stimulating factors: the American Society of Clinical Oncology survey. The Health Services Research Committee of the American Society of Clinical Oncology. J Clin Oncol. 1996 Sep; 14(9):2511-20.
Score: 0.005
-
Peginesatide for the treatment of anemia due to chronic kidney disease - an unfulfilled promise. Expert Opin Drug Saf. 2016 Oct; 15(10):1421-6.
Score: 0.005
-
Cardiovascular disease incidence among females in South Carolina by type of oral contraceptives, 2000-2013: a retrospective cohort study. Arch Gynecol Obstet. 2016 11; 294(5):991-997.
Score: 0.005
-
Western impressions of the Hong Kong health care system. West J Med. 1996 Jul-Aug; 165(1-2):37-42.
Score: 0.005
-
Assessing Colorectal Cancer Screening Adherence of Medicare Fee-for-Service Beneficiaries Age 76 to 95 Years. J Oncol Pract. 2016 06; 12(6):e670-80.
Score: 0.005
-
Cost-effective models for flutamide for prostate carcinoma patients: are they helpful to policy makers? Cancer. 1996 May 01; 77(9):1854-61.
Score: 0.005
-
A review of the costs, cost-effectiveness and third-party charges of bone marrow transplantation. Stem Cells. 1996 May; 14(3):312-9.
Score: 0.005
-
Association of mannose-binding lectin levels and invasive fungal disease in hematologic malignancy patients receiving myelosuppressive chemotherapy or allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant. 2016 Sep; 51(9):1228-32.
Score: 0.005
-
Performance measurement in prostate cancer care: beyond report cards. Urology. 1996 Mar; 47(3):356-65.
Score: 0.005
-
Progestin and breast cancer risk: a systematic review. Breast Cancer Res Treat. 2016 Jan; 155(1):3-12.
Score: 0.005
-
Economic analysis during phase III clinical trials: who, what, when, where, and why? Oncology (Williston Park). 1995 Nov; 9(11 Suppl):169-75.
Score: 0.005
-
Free-riding and the prisoner's dilemma: problems in funding economic analyses of phase III cancer clinical trials. J Clin Oncol. 1995 Sep; 13(9):2457-63.
Score: 0.005
-
Racial differences in care among hospitalized patients with Pneumocystis carinii pneumonia in Chicago, New York, Los Angeles, Miami, and Raleigh-Durham. Arch Intern Med. 1995 Aug 7-21; 155(15):1586-92.
Score: 0.005
-
Patterns of care for and outcomes of Pneumocystis carinii pneumonia among persons with transfusion-acquired AIDS. Transfusion. 1995 Aug; 35(8):674-8.
Score: 0.005
-
Editorial Comment. Urology. 2015 Jul; 86(1):78.
Score: 0.005
-
Granulocyte-macrophage colony-stimulating factor as adjunct therapy in relapsed lymphoid malignancy: implications for economic analyses of phase III clinical trials. Stem Cells. 1995 Jul; 13(4):414-20.
Score: 0.005
-
Score cards for AIDS care. J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Jul 01; 9(3):286-90.
Score: 0.005
-
Empirically treated Pneumocystis carinii pneumonia in Los Angeles, Chicago, and Miami: 1987-1990. J Infect Dis. 1995 Jul; 172(1):312-5.
Score: 0.005
-
Multi-city study of quality of care for HIV-related Pneumocystis carinii pneumonia: successfully collecting highly sensitive information. Clin Perform Qual Health Care. 1995 Jul-Sep; 3(3):140-6.
Score: 0.005
-
Cost-effectiveness models of clinical trials of new pharmaceuticals for AIDS-related Pneumocystis carinii pneumonia: are they helpful to policy makers? Clin Perform Qual Health Care. 1995 Jul-Sep; 3(3):156-64.
Score: 0.005
-
Poor responder to plasma exchange therapy in acquired thrombotic thrombocytopenic purpura is associated with ADAMTS13 inhibitor boosting: visualization of an ADAMTS13 inhibitor complex and its proteolytic clearance from plasma. Transfusion. 2015 Oct; 55(10):2321-30.
Score: 0.005
-
High PSA anxiety and low health literacy skills: drivers of early use of salvage ADT among men with biochemically recurrent prostate cancer after radiotherapy? Ann Oncol. 2015 Jul; 26(7):1390-5.
Score: 0.005
-
Costs of care and outcomes for high-dose therapy and autologous transplantation for lymphoid malignancies: results from the University of Nebraska 1987 through 1991. J Clin Oncol. 1995 Apr; 13(4):969-73.
Score: 0.005
-
Estimating the cost effectiveness of total androgen blockade with flutamide in M1 prostate cancer. Urology. 1995 Apr; 45(4):633-40.
Score: 0.005
-
The learning curve for AIDS-related Pneumocystis carinii pneumonia: experience from 3,981 cases in Veterans Affairs Hospitals 1987-1991. J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Apr 01; 8(4):373-8.
Score: 0.005
-
Barriers to condom use and needle cleaning among impoverished minority female injection drug users and partners of injection drug users. Public Health Rep. 1995 Mar-Apr; 110(2):166-72.
Score: 0.005
-
Sustaining mammography screening among the medically underserved: a follow-up evaluation. J Womens Health (Larchmt). 2015 Apr; 24(4):291-8.
Score: 0.005
-
Costs of terminal care for people with AIDS. AIDS Patient Care. 1995 Feb; 9(1):7-9.
Score: 0.005
-
Informal caregivers of persons with AIDS. J Palliat Care. 1995; 11(2):10-8.
Score: 0.005
-
Economics of Malignant Gliomas: A Critical Review. J Oncol Pract. 2015 01; 11(1):e59-65.
Score: 0.005
-
A rapid preadmission method for predicting inpatient course of disease for patients with HIV-related Pneumocystis carinii pneumonia. Am J Respir Crit Care Med. 1994 Dec; 150(6 Pt 1):1503-7.
Score: 0.005
-
The association between race and treatment regret among men with recurrent prostate cancer. Prostate Cancer Prostatic Dis. 2015 Mar; 18(1):38-42.
Score: 0.005
-
Systemic therapy in men with metastatic castration-resistant prostate cancer:American Society of Clinical Oncology and Cancer Care Ontario clinical practice guideline. J Clin Oncol. 2014 Oct 20; 32(30):3436-48.
Score: 0.005
-
Economic analyses of clinical trials in cancer: are they helpful to policy makers? Stem Cells. 1994 Jul; 12(4):424-9.
Score: 0.004
-
Racial differences in cervical cancer mortality in Chicago. Am J Public Health. 1994 Jun; 84(6):1007-9.
Score: 0.004
-
Azithromycin and levofloxacin use and increased risk of cardiac arrhythmia and death. Ann Fam Med. 2014 Mar-Apr; 12(2):121-7.
Score: 0.004
-
Economic analysis in phase III clinical cancer trials. Cancer Invest. 1994; 12(3):336-42.
Score: 0.004
-
Improving mammography screening among the medically underserved. J Gen Intern Med. 2014 Apr; 29(4):628-35.
Score: 0.004
-
Cross-sectional analysis of Met235-->Thr variant of angiotensinogen gene in severe, familial hypertension. Biochem Biophys Res Commun. 1993 Dec 15; 197(2):833-9.
Score: 0.004
-
Erythropoietin, a novel repurposed drug: an innovative treatment for wound healing in patients with diabetes mellitus. Wound Repair Regen. 2014 Jan-Feb; 22(1):23-33.
Score: 0.004
-
Improved outcomes in intensive care units for AIDS-related Pneumocystis carinii pneumonia: 1987-1991. J Acquir Immune Defic Syndr (1988). 1993 Dec; 6(12):1319-21.
Score: 0.004
-
Strategies to improve repeat fecal occult blood testing cancer screening. Cancer Epidemiol Biomarkers Prev. 2014 Jan; 23(1):134-43.
Score: 0.004
-
Improving colon cancer screening in community clinics. Cancer. 2013 Nov 01; 119(21):3879-86.
Score: 0.004
-
Angiotensin receptor blockers: are they related to lung cancer? J Hypertens. 2013 Aug; 31(8):1669-75.
Score: 0.004
-
The utility of prostate-specific antigen in the management of advanced prostate cancer. BJU Int. 2013 Sep; 112(5):548-60.
Score: 0.004
-
Reply to S.P.Sura et al. J Clin Oncol. 2013 Jul 01; 31(19):2512.
Score: 0.004
-
Angiotensin receptor blockers and risk of prostate cancer among United States veterans. J Clin Pharmacol. 2013 Jul; 53(7):773-8.
Score: 0.004
-
Does experience improve hospital performance in treating patients with AIDS? Health Policy. 1993 Apr; 24(1):35-43.
Score: 0.004
-
Ensuring comprehensive assessment of urinary problems in prostate cancer through patient-physician concordance. Urol Oncol. 2014 Jan; 32(1):26.e25-31.
Score: 0.004
-
Outcomes of specialized and traditional AIDS counseling programs for impoverished women of color. Res Nurs Health. 1993 Feb; 16(1):11-21.
Score: 0.004
-
Reduced penile size and treatment regret in men with recurrent prostate cancer after surgery, radiotherapy plus androgen deprivation, or radiotherapy alone. Urology. 2013 Jan; 81(1):130-4.
Score: 0.004
-
Unintended consequences of health information technology: evidence from veterans affairs colorectal cancer oncology watch intervention. J Clin Oncol. 2012 Nov 10; 30(32):3947-52.
Score: 0.004
-
Cost-effectiveness comparison of response strategies to a large-scale anthrax attack on the chicago metropolitan area: impact of timing and surge capacity. Biosecur Bioterror. 2012 Sep; 10(3):264-79.
Score: 0.004
-
Health care use by human immunodeficiency virus-infected students at a California student health service. West J Med. 1992 Jul; 157(1):41-3.
Score: 0.004
-
Acquired idiopathic ADAMTS13 activity deficient thrombotic thrombocytopenic purpura in a population from Japan. PLoS One. 2012; 7(3):e33029.
Score: 0.004
-
Amiodarone-associated optic neuropathy: a critical review. Am J Med. 2012 May; 125(5):447-53.
Score: 0.004
-
Granulocyte-macrophage colony-stimulating factor (GM-CSF) as adjunct therapy in relapsed Hodgkin disease. Ann Intern Med. 1992 Feb 01; 116(3):177-82.
Score: 0.004
-
Relation between hospital experience and in-hospital mortality for patients with AIDS-related Pneumocystis carinii pneumonia: experience from 3,126 cases in New York City in 1987. J Acquir Immune Defic Syndr (1988). 1992; 5(9):856-64.
Score: 0.004
-
Medical care costs of intravenous drug users with AIDS in Brooklyn. J Acquir Immune Defic Syndr (1988). 1992; 5(1):1-6.
Score: 0.004
-
Cardiovascular comorbidity and treatment regret in men with recurrent prostate cancer. BJU Int. 2012 Jul; 110(2):201-5.
Score: 0.004
-
Patterns of care related to age of men with prostate cancer. Cancer. 1991 May 15; 67(10):2633-41.
Score: 0.004
-
Cancer therapy associated bone loss: implications for hip fractures in mid-life women with breast cancer. Clin Cancer Res. 2011 Feb 01; 17(3):560-8.
Score: 0.004
-
Studying cancer-related fatigue: report of the NCCN scientific research committee. J Natl Compr Canc Netw. 2010 Dec; 8(12):1331-9.
Score: 0.003
-
Screening colonoscopy vs flexible sigmoidoscopy. JAMA. 2010 Nov 10; 304(18):2016-7; author reply 2017-8.
Score: 0.003
-
American Society of Hematology/American Society of Clinical Oncology clinical practice guideline update on the use of epoetin and darbepoetin in adult patients with cancer. Blood. 2010 Nov 18; 116(20):4045-59.
Score: 0.003
-
American Society of Clinical Oncology/American Society of Hematology clinical practice guideline update on the use of epoetin and darbepoetin in adult patients with cancer. J Clin Oncol. 2010 Nov 20; 28(33):4996-5010.
Score: 0.003
-
The relation between resource use and in-hospital mortality for patients with acquired immunodeficiency syndrome-related Pneumocystis carinii pneumonia. Arch Intern Med. 1990 Jul; 150(7):1447-52.
Score: 0.003
-
Multiple domains of ADAMTS13 are targeted by autoantibodies against ADAMTS13 in patients with acquired idiopathic thrombotic thrombocytopenic purpura. Haematologica. 2010 Sep; 95(9):1555-62.
Score: 0.003
-
Feasibility and effectiveness of the NEST13+ as a screening tool for advanced illness care needs. J Palliat Med. 2010 Feb; 13(2):161-9.
Score: 0.003
-
Evaluation of a potential clinical interaction between ceftriaxone and calcium. Antimicrob Agents Chemother. 2010 Apr; 54(4):1534-40.
Score: 0.003
-
AIDS care needs wider QA effort. QA Rev. 1989 Dec; 1(5):6.
Score: 0.003
-
Costs and cost effectiveness of a health care provider-directed intervention to promote colorectal cancer screening. J Clin Oncol. 2009 Nov 10; 27(32):5370-5.
Score: 0.003
-
The COMPARE Registry: design and baseline patterns of care for men with biochemical failure after definitive treatment of localized prostate cancer. Urology. 2010 Mar; 75(3):623-9.
Score: 0.003
-
The relation between hospital experience and in-hospital mortality for patients with AIDS-related PCP. JAMA. 1989 May 26; 261(20):2975-9.
Score: 0.003
-
Challenges in secondary stroke prevention: prevalence of multiple metabolic risk factors, including abnormal glycaemia, in ischaemic stroke and transient ischaemic attack. Intern Med J. 2010 Apr; 40(4):275-80.
Score: 0.003
-
A health services research agenda for cellular, molecular and genomic technologies in cancer care. Public Health Genomics. 2009; 12(4):233-44.
Score: 0.003
-
Small bowel cancer in the United States: changes in epidemiology, treatment, and survival over the last 20 years. Ann Surg. 2009 Jan; 249(1):63-71.
Score: 0.003
-
Myeloid growth factors. J Natl Compr Canc Netw. 2009 Jan; 7(1):64-83.
Score: 0.003
-
Hepatotoxicity associated with long- versus short-course HIV-prophylactic nevirapine use: a systematic review and meta-analysis from the Research on Adverse Drug events And Reports (RADAR) project. Drug Saf. 2009; 32(2):147-58.
Score: 0.003
-
Venous thromboembolic disease. NCCN. Clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2008 Sep; 6(8):716-53.
Score: 0.003
-
Cancer- and chemotherapy-induced anemia. J Natl Compr Canc Netw. 2008 Jul; 6(6):536-64.
Score: 0.003
-
Adipokines and cytokines in non-alcoholic fatty liver disease. Aliment Pharmacol Ther. 2008 Mar 01; 27(5):412-21.
Score: 0.003
-
Costs and cost-effectiveness of a low-intensity patient-directed intervention to promote colorectal cancer screening. J Clin Oncol. 2007 Nov 20; 25(33):5248-53.
Score: 0.003
-
Development and validation of a short-form, rapid estimate of adult literacy in medicine. Med Care. 2007 Nov; 45(11):1026-33.
Score: 0.003
-
Dermatologic challenges in cancer patients and survivors. Oncology (Williston Park). 2007 Nov; 21(12):1462-72; discussion 1473, 1476, 1481 passim.
Score: 0.003
-
Use of epoetin and darbepoetin in patients with cancer: 2007 American Society of Hematology/American Society of Clinical Oncology clinical practice guideline update. Blood. 2008 Jan 01; 111(1):25-41.
Score: 0.003
-
Use of epoetin and darbepoetin in patients with cancer: 2007 American Society of Clinical Oncology/American Society of Hematology clinical practice guideline update. J Clin Oncol. 2008 Jan 01; 26(1):132-49.
Score: 0.003
-
Outcomes and complications associated with off-label and untested use of drug-eluting stents. JAMA. 2007 May 09; 297(18):1992-2000.
Score: 0.003
-
G-CSF is not necessary to maintain over 99% dose-intensity with ABVD in the treatment of Hodgkin lymphoma: low toxicity and excellent outcomes in a 10-year analysis. Br J Haematol. 2007 Jun; 137(6):545-52.
Score: 0.003
-
Initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer: 2006 update of an American Society of Clinical Oncology practice guideline. J Clin Oncol. 2007 Apr 20; 25(12):1596-605.
Score: 0.003
-
Breakthrough zygomycosis after voriconazole administration among patients with hematologic malignancies who receive hematopoietic stem-cell transplants or intensive chemotherapy. Bone Marrow Transplant. 2007 Apr; 39(7):425-9.
Score: 0.003
-
Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy. J Natl Cancer Inst. 2007 Feb 07; 99(3):196-205.
Score: 0.003
-
Myeloid growth factors. Clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2007 Feb; 5(2):188-202.
Score: 0.003
-
The economics of brain metastases. Cancer Treat Res. 2007; 136:23-9.
Score: 0.003
-
Hairy cell leukemia and mucormycosis. Treatment with alpha-2 interferon. Am J Med. 1986 Dec; 81(6):1065-7.
Score: 0.003
-
Literacy, self-efficacy, and HIV medication adherence. Patient Educ Couns. 2007 Feb; 65(2):253-60.
Score: 0.003
-
Venous thromboembolic disease. Clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2006 Oct; 4(9):838-69.
Score: 0.003
-
Gemtuzumab ozogamicin-associated sinusoidal obstructive syndrome (SOS): an overview from the research on adverse drug events and reports (RADAR) project. Leuk Res. 2007 May; 31(5):599-604.
Score: 0.003
-
Hyponatremia and other toxic effects during a phase I trial of recombinant human gamma interferon and vinblastine. Cancer Treat Rep. 1986 Sep; 70(9):1081-4.
Score: 0.003
-
Low literacy impairs comprehension of prescription drug warning labels. J Gen Intern Med. 2006 Aug; 21(8):847-51.
Score: 0.003
-
Recombinant human erythropoietins and cancer patients: updated meta-analysis of 57 studies including 9353 patients. J Natl Cancer Inst. 2006 May 17; 98(10):708-14.
Score: 0.003
-
2006 update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline. J Clin Oncol. 2006 Jul 01; 24(19):3187-205.
Score: 0.003
-
Social stigma concerns and HIV medication adherence. AIDS Patient Care STDS. 2006 May; 20(5):359-68.
Score: 0.003
-
Eradication of Helicobacter pylori for non-ulcer dyspepsia. Cochrane Database Syst Rev. 2006 Apr 19; (2):CD002096.
Score: 0.003
-
Staging and therapy of orbital lymphomas. Cancer. 1986 Mar 15; 57(6):1204-8.
Score: 0.003
-
Hypersensitivity cases associated with drug-eluting coronary stents: a review of available cases from the Research on Adverse Drug Events and Reports (RADAR) project. J Am Coll Cardiol. 2006 Jan 03; 47(1):175-81.
Score: 0.002
-
A qualitative study of literacy and patient response to HIV medication adherence questionnaires. J Health Commun. 2005 Sep; 10(6):509-17.
Score: 0.002
-
Patient preferences in prostate cancer: a clinician's guide to understanding health utilities. Clin Prostate Cancer. 2005 Jun; 4(1):15-23.
Score: 0.002
-
High rates of adverse drug events in a highly computerized hospital. Arch Intern Med. 2005 May 23; 165(10):1111-6.
Score: 0.002
-
Prediction rule for atrial fibrillation after major noncardiac thoracic surgery. Ann Thorac Surg. 2005 May; 79(5):1698-703.
Score: 0.002
-
Recombinant human erythropoietin and overall survival in cancer patients: results of a comprehensive meta-analysis. J Natl Cancer Inst. 2005 Apr 06; 97(7):489-98.
Score: 0.002
-
Development of a brief survey on colon cancer screening knowledge and attitudes among veterans. Prev Chronic Dis. 2005 Apr; 2(2):A11.
Score: 0.002
-
Eradication of Helicobacter pylori for non-ulcer dyspepsia. Cochrane Database Syst Rev. 2005 Jan 25; (1):CD002096.
Score: 0.002
-
Clinical characteristics of erythropoietin-associated pure red cell aplasia. Best Pract Res Clin Haematol. 2005; 18(3):467-72.
Score: 0.002
-
Epoetin-induced pure red-cell aplasia (PRCA): preliminary results from the research on adverse drug events and reports (RADAR) group. Best Pract Res Clin Haematol. 2005; 18(3):481-9.
Score: 0.002
-
Genotyping and functional analysis of the D104N variant of human endostatin. Cancer Biol Ther. 2004 Dec; 3(12):1298-303.
Score: 0.002
-
Cost minimization study of image-guided core biopsy versus surgical excisional biopsy for women with abnormal mammograms. J Clin Oncol. 2004 Jun 15; 22(12):2430-7.
Score: 0.002
-
American Society of Clinical Oncology recommendations for the initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer. J Clin Oncol. 2004 Jul 15; 22(14):2927-41.
Score: 0.002
-
HIV-related pneumonia care in older patients hospitalized in the early HAART era. AIDS Patient Care STDS. 2004 Feb; 18(2):99-107.
Score: 0.002
-
Merging claims databases with a tumor registry to evaluate variations in cancer mortality: results from a pilot study of 698 colorectal cancer patients treated at one hospital in the 1990s. Cancer Invest. 2004; 22(2):225-33.
Score: 0.002
-
Surgical outcomes of patients with gastric carcinoma: the importance of primary tumor location and microvessel invasion. Surgery. 2003 Oct; 134(4):720-7; discussion 727-9.
Score: 0.002
-
Increased incidence of renal parenchymal carcinoma in the Northern and Yorkshire region of England, 1978-1997. Eur J Cancer. 2003 May; 39(7):961-7.
Score: 0.002
-
A rapid staging system for predicting mortality from HIV-associated community-acquired pneumonia. Chest. 2003 Apr; 123(4):1151-60.
Score: 0.002
-
Post-cardiac catheterization access site complications and low-molecular -weight heparin following cardiac catheterization. J Invasive Cardiol. 2003 Feb; 15(2):60-2.
Score: 0.002
-
Quality of life after a diagnosis of prostate cancer among men of lower socioeconomic status: results from the Veterans Affairs Cancer of the Prostate Outcomes Study. Urology. 2003 Jan; 61(1):172-8.
Score: 0.002
-
Use of epoetin in patients with cancer: evidence-based clinical practice guidelines of the American Society of Clinical Oncology and the American Society of Hematology. Blood. 2002 Oct 01; 100(7):2303-20.
Score: 0.002
-
Pilot study of a utilities-based treatment decision intervention for prostate cancer patients. Clin Prostate Cancer. 2002 Sep; 1(2):105-14.
Score: 0.002
-
Systematic review and meta-analysis of monotherapy compared with combined androgen blockade for patients with advanced prostate carcinoma. Cancer. 2002 Jul 15; 95(2):361-76.
Score: 0.002
-
The association of health literacy with cervical cancer prevention knowledge and health behaviors in a multiethnic cohort of women. Am J Obstet Gynecol. 2002 May; 186(5):938-43.
Score: 0.002
-
Platelet transfusion for patients with cancer: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol. 2001 Mar 01; 19(5):1519-38.
Score: 0.002
-
2000 update of recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines. American Society of Clinical Oncology Growth Factors Expert Panel. J Clin Oncol. 2000 Oct 15; 18(20):3558-85.
Score: 0.002
-
Testicular health awareness in pubertal males. J Urol. 2000 Sep; 164(3 Pt 2):1115-7.
Score: 0.002
-
The uncertainty principle and industry-sponsored research. Lancet. 2000 Aug 19; 356(9230):635-8.
Score: 0.002
-
IL-1beta and TNF-alpha in prostatic secretions are indicators in the evaluation of men with chronic prostatitis. J Urol. 2000 Jul; 164(1):214-8.
Score: 0.002
-
Purchasing oncology services. Kerr L. White Institute/American Cancer Society Task Force on Purchasing Oncology Services. Cancer. 2000 Jun 15; 88(12):2876-86.
Score: 0.002
-
Single-therapy androgen suppression in men with advanced prostate cancer: a systematic review and meta-analysis. Ann Intern Med. 2000 Apr 04; 132(7):566-77.
Score: 0.002
-
Nosocomial tuberculosis prevention measures among two groups of US hospitals, 1992 to 1996. Chest. 2000 Feb; 117(2):380-4.
Score: 0.002
-
Delays in tuberculosis isolation and suspicion among persons hospitalized with HIV-related pneumonia. Chest. 2000 Jan; 117(1):110-6.
Score: 0.002
-
Maximal androgen blockade for advanced prostate cancer. Cochrane Database Syst Rev. 2000; (2):CD001526.
Score: 0.002
-
Comparative study of the clinical efficacy of two dosing regimens of flutamide. Mol Urol. 2000; 4(3):259-63;discussion 265.
Score: 0.002
-
An evidence-based analysis of the effect of busulfan, hydroxyurea, interferon, and allogeneic bone marrow transplantation in treating the chronic phase of chronic myeloid leukemia: developed for the American Society of Hematology. Blood. 1999 Sep 01; 94(5):1517-36.
Score: 0.002
-
Costs of care associated with high-dose therapy and autologous transplantation for non-Hodgkin's lymphoma: results from the University of Nebraska Medical Center 1989 to 1995. Bone Marrow Transplant. 1999 Sep; 24(6):679-84.
Score: 0.002
-
QOL and outcomes research in prostate cancer patients with low socioeconomic status. Oncology (Williston Park). 1999 Jun; 13(6):823-32; discussion 835-8.
Score: 0.002
-
Relative effectiveness and cost-effectiveness of methods of androgen suppression in the treatment of advanced prostate cancer. Evid Rep Technol Assess (Summ). 1999 May; (4):i-x, 1-246, I1-36, passim.
Score: 0.002
-
Perceptions of cisplatin-related toxicity among ovarian cancer patients and gynecologic oncologists. Gynecol Oncol. 1998 Dec; 71(3):369-75.
Score: 0.002
-
Variations in intensive care unit utilization for patients with human immunodeficiency virus-related Pneumocystis carinii pneumonia: importance of hospital characteristics and geographic location. Crit Care Med. 1998 Apr; 26(4):668-75.
Score: 0.001
-
Economic analyses of bone marrow and blood stem cell transplantation for leukemias and lymphoma: what do we know? Bone Marrow Transplant. 1998 Apr; 21(7):641-50.
Score: 0.001
-
Performance measurement in pneumonia care: beyond report cards. Mayo Clin Proc. 1998 Jan; 73(1):5-9.
Score: 0.001
-
Comparison of perspectives on prostate cancer: analyses of survey data. Urology. 1997 Sep; 50(3):366-72.
Score: 0.001
-
Approaches to prostate cancer by managed care organizations. Urology. 1997 Jul; 50(1):79-86.
Score: 0.001
-
Economic analyses of new technologies: the case of stem-cell transplantation. J Clin Oncol. 1997 Jan; 15(1):2-4.
Score: 0.001
-
AIDS-related Pneumocystis carinii pneumonia in older patients. J Gen Intern Med. 1996 Oct; 11(10):591-6.
Score: 0.001
-
Predictors of resource utilization for hospitalized patients with Pneumocystis carinii pneumonia (PCP): a summary of effects from the multi-city study of quality of PCP care. J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Aug 01; 12(4):379-85.
Score: 0.001
-
Self-perceived unmet health care needs of persons enrolled in HIV care. J Community Health. 1996 Jun; 21(3):183-98.
Score: 0.001
-
Estimating the cost effectiveness of atovaquone versus intravenous pentamidine in the treatment of mild-to-moderate Pneumocystis carinii pneumonia. Pharmacoeconomics. 1996 Jun; 9(6):525-34.
Score: 0.001
-
A program for eradication of hepatitis B from Taiwan by a 10-year, four-dose vaccination program. Cancer Causes Control. 1996 May; 7(3):305-11.
Score: 0.001
-
The impact of housing status on health care utilization among persons with HIV disease. J Health Care Poor Underserved. 1996; 7(1):36-49.
Score: 0.001
-
Relationship between procedures and health insurance for critically ill patients with Pneumocystis carinii pneumonia. Am J Respir Crit Care Med. 1995 Nov; 152(5 Pt 1):1435-42.
Score: 0.001
-
Predictors of maintained high-risk behaviors among impoverished women. Public Health Rep. 1995 Sep-Oct; 110(5):600-6.
Score: 0.001
-
Evaluation of two AIDS education programs for impoverished Latina women. AIDS Educ Prev. 1994 Aug; 6(4):296-309.
Score: 0.001
-
Human T cell leukemia virus (HTLV-I/II) serodiagnostic testing: disparate results among a cohort of intravenous drug users. AIDS Res Hum Retroviruses. 1993 Oct; 9(10):1043-50.
Score: 0.001
-
Differences between men and women with HIV-related Pneumocystis carinii pneumonia: experience from 3,070 cases in New York City in 1987. J Acquir Immune Defic Syndr (1988). 1993 Jun; 6(6):617-23.
Score: 0.001
-
Role of granulocyte-macrophage colony stimulating factor (GM-CSF) after autologous bone marrow transplantation for Hodgkin's disease. Anticancer Drugs. 1993 May; 4 Suppl 1:13-6.
Score: 0.001
-
AIDS-related knowledge, perceptions, and behaviors among impoverished minority women. Am J Public Health. 1993 Jan; 83(1):65-71.
Score: 0.001
-
Health care in the Czech Republic. A system in transition. JAMA. 1992 May 13; 267(18):2461-6.
Score: 0.001
-
Human T-cell leukemia virus type-I/II (HTLV-I/II) serologic testing: the importance of assaying for the full complement of viral antigens. Viral Immunol. 1992; 5(2):105-11.
Score: 0.001
-
A prospective study of complications in Hickman right-atrial catheters in marrow transplant patients. JPEN J Parenter Enteral Nutr. 1990 Jan-Feb; 14(1):27-30.
Score: 0.001
-
Evaluating institutional performance in AIDS-associated Pneumocystis carinii pneumonia: a risk adjustment approach. J Clin Epidemiol. 1989; 42(5):421-5.
Score: 0.001
-
Patterns of gallium-67 scintigraphy in patients with acquired immunodeficiency syndrome and the AIDS related complex. J Nucl Med. 1987 Jul; 28(7):1103-6.
Score: 0.001